Michael A. Sherman
CIK 1509463 · Chief Executive Officer · last filed 2025-06-13
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$0
Companies
5
Total Filings
43
Lifetime Open-Market Net
-$130.1K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| HOWL | Director | — | $0.38 | — | $0 | 5 | 2025-06-13 |
| CHIMERIX INC (CMRX) Delisted | Chief Executive Officer | 0 | $8.54 | $0 | $307.6K | 12 | 2025-04-21 |
| BIOSPECIFICS TECHNOLOGIES CORP (BSTC) Delisted | Director | 0 | — | — | $0 | 3 | 2020-12-02 |
| ENDOCYTE INC (ECYT) Delisted | President and CEO | 0 | — | — | -$437.8K | 19 | 2018-12-21 |
| Mead Johnson Nutrition Co (MJN) Delisted | Director | 0 | — | — | $0 | 4 | 2017-06-15 |
Recent Filings · Page 5 of 5
43 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2011-12-16 | ENDOCYTE INC (ECYT) Delisted | Exer (M) | +20,942 | $41.5K | EDGAR |
| 2011-04-18 | ENDOCYTE INC (ECYT) Delisted | Grant (A) | — | $0 | EDGAR |
| 2011-02-11 | ENDOCYTE INC (ECYT) Delisted | Conv (C) | +19,919 | $0 | EDGAR |
Showing 41–43 of 43
Prev
Page 5 of 5
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.